BridgeMD
New treatment option for Hepatic Resection
Official title Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
ClinicalTrials.gov ID: NCT04849455
What this study is testing
What is 0.2% ropivacaine local anesthetic continuous erector spinae plane block?
0.2% ropivacaine local anesthetic continuous erector spinae plane block is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for hepatic resection.
Also referred to as Treatment.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- undergoing hepatic resection
- Admitting service requests APS consult
- \>18 years old and able to provide consent
You likely can't join if
- pregnancy
- incarceration
- inability to communicate with the investigators and hospital staff
- severe hepatic disease
- chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
- BMI \> 40 kg/m2
See the full eligibility criteria
- undergoing hepatic resection
- Admitting service requests APS consult
- \>18 years old and able to provide consent
- pregnancy
- incarceration
- inability to communicate with the investigators and hospital staff
- severe hepatic disease
- chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
- BMI \> 40 kg/m2
- allergy to study medications (lidocaine, ropivacaine)
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.